Exact Mass: 589.0948112000001

Exact Mass Matches: 589.0948112000001

Found 65 metabolites which its exact mass value is equals to given mass value 589.0948112000001, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

ADP-glucose

[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy})phosphinic acid

C16H25N5O15P2 (589.0822360000001)


ADP-glucose serves as the glycosyl donor for formation of bacterial glycogen, amylose in green algae, and amylopectin in higher plants. ADP-glucose has been found to be a metabolite of Escherichia (PMID: 25102309). Acquisition and generation of the data is financially supported in part by CREST/JST.

   

GDP-L-fucose

[({[(2R,3S,4R,5R)-5-(2-amino-6-oxo-6,9-dihydro-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]({[(3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy})phosphinic acid

C16H25N5O15P2 (589.0822360000001)


GDP-L-fucose is a sugar nucleotide and a readily available source of fucose. Fucose is a deoxyhexose that is found in nearly all plant and animal species. The monosaccharide plays several important metabolic roles in complex carbohydrates and in glycoproteins. Fucosylated oligosaccharides are involved in cell-cell recognition, selectin-mediated leukocyte-endothelial adhesion, and mouse embryogenesis. They form the basis of the Lewis-type blood group antigens, are involved in the formation of atherosclerosis, and mediate host-bacterial interactions. A decrease in the availability of fucose is associated with leukocyte adhesion deficiency type-II disorder, and fucosylated glycoproteins have been implicated in memory processes. Fucose is made available during the synthesis of fucosylated glycolipids, oligosaccharides, and glycoproteins via a sugar nucleotide intermediate, specifically GDP-L-fucose. GTP-L-fucose pyrophosphorylase (GFPP, E. C. 2.7.7.30) catalyzes the reversible condensation of guanosine triphosphate and beta-L-fucose-1-phosphate to form the nucleotide-sugar GDP-L-fucose. The enzyme functions primarily in the mammalian liver and kidney to salvage free L-fucose during the breakdown of glycolipids and glycoproteins. (PMID: 16086588). Gdp-l-fucose, also known as gdp fucose or guanosine diphosphate fucose, is a member of the class of compounds known as purine nucleotide sugars. Purine nucleotide sugars are purine nucleotides bound to a saccharide derivative through the terminal phosphate group. Gdp-l-fucose is slightly soluble (in water) and a moderately acidic compound (based on its pKa). Gdp-l-fucose can be found in a number of food items such as breadnut tree seed, okra, pineapple, and pitanga, which makes gdp-l-fucose a potential biomarker for the consumption of these food products. Gdp-l-fucose can be found primarily throughout most human tissues. Gdp-l-fucose exists in all living organisms, ranging from bacteria to humans. In humans, gdp-l-fucose is involved in a couple of metabolic pathways, which include fructose and mannose degradation and fructose intolerance, hereditary. Gdp-l-fucose is also involved in fructosuria, which is a metabolic disorder. Acquisition and generation of the data is financially supported in part by CREST/JST.

   

UDP-2-acetamido-4-dehydro-2,6-dideoxyglucose

UDP-2-acetamido-4-dehydro-2,6-dideoxyglucose; UDP-2-acetamido-2,6-dideoxy-alpha-D-xylo-hexos-4-ulose; UDP-2-acetamido-2,6-dideoxy-alpha-D-xylo-hex-4-ulose

C17H25N3O16P2 (589.071003)


   

dTDP-4-acetamido-4,6-dideoxy-D-galactose

{[(3R,4S,6R)-5-acetamido-3,4-dihydroxy-6-methyloxan-2-yl]oxy}({[hydroxy({[3-hydroxy-5-(5-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)oxolan-2-yl]methoxy})phosphoryl]oxy})phosphinic acid

C18H29N3O15P2 (589.1073864000001)


dTDP-4-acetamido-4,6-dideoxy-D-galactose reacts with undecaprenyl N-acetyl-glucosaminyl-N-acetyl-mannosaminuronate to produce undecaprenyl N-acetyl-glucosaminyl-N-acetyl-mannosaminuronate-4-acetamido-4,6-dideoxy-D-galactose pyrophosphate and dTDP. The reaction is catalyzed by certain members of the fucosyltransferase family of enzymes. [HMDB] dTDP-4-acetamido-4,6-dideoxy-D-galactose reacts with undecaprenyl N-acetyl-glucosaminyl-N-acetyl-mannosaminuronate to produce undecaprenyl N-acetyl-glucosaminyl-N-acetyl-mannosaminuronate-4-acetamido-4,6-dideoxy-D-galactose pyrophosphate and dTDP. The reaction is catalyzed by certain members of the fucosyltransferase family of enzymes.

   

dTDP-4-dimethylamino-4,6-dideoxy-5-C-methyl-D-allose

dTDP-4-dimethylamino-4,6-dideoxy-5-C-methyl-L-mannose

C19H33N3O14P2 (589.1437698000001)


   

dTDP-3-acetamido-3,6-dideoxy-alpha-D-galactopyranose

dTDP-3-acetamido-3,6-dideoxy-alpha-D-galactopyranose

C18H29N3O15P2 (589.1073864000001)


   

GDP-D-Rhamnose

[({[(2R,3S,4R,5R)-5-(2-amino-6-oxo-6,9-dihydro-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]({[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy})phosphinic acid

C16H25N5O15P2 (589.0822360000001)


GDP-D-rhamnose is produced in virus-infected cells. Rhamnose is components of the glycans attached to capsid protein, the pathway could circumvent a limited supply of GDP sugars by the algal host.(http://www.jbc.org/cgi/content/abstract/278/24/21559) [HMDB] GDP-D-rhamnose is produced in virus-infected cells. Rhamnose is components of the glycans attached to capsid protein, the pathway could circumvent a limited supply of GDP sugars by the algal host.(http://www.jbc.org/cgi/content/abstract/278/24/21559).

   

ADP-Mannose

[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]({[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy})phosphinic acid

C16H25N5O15P2 (589.0822360000001)


ADP-mannose is one of the major substrates of human hydrolases. Nudix hydrolases catalyze the hydrolysis of a variety of nucleoside diphosphate derivatives, and ADP-sugar pyrophosphatase are non-specific nucleoside diphosphosugar or diphosphoalcohol (NDP-X) pyrophosphatases, which hydrolyse some nonreducing NDP-X substrates. It has been found in erythrocytes, placenta and liver. (PMID: 1128712, 10722730, 9693963) [HMDB] ADP-mannose is one of the major substrates of human hydrolases. Nudix hydrolases catalyze the hydrolysis of a variety of nucleoside diphosphate derivatives, and ADP-sugar pyrophosphatase are non-specific nucleoside diphosphosugar or diphosphoalcohol (NDP-X) pyrophosphatases, which hydrolyse some nonreducing NDP-X substrates. It has been found in erythrocytes, placenta and liver. (PMID: 1128712, 10722730, 9693963).

   

UDP-2-acetamido-2,6-dideoxy-beta-L-arabino-hex-4-ulose

UDP-2-acetamido-2,6-dideoxy-beta-L-arabino-hexos-4-ulose

C17H25N3O16P2 (589.071003)


   

[(2~{R},3~{R},4~{S},5~{S},6~{R})-4-acetamido-6-methyl-3,5-bis(oxidanyl)oxan-2-yl] [[(2~{R},3~{S},5~{R})-5-[5-methyl-2,4-bis(oxidanylidene)pyrimidin-1-yl]-3-oxidanyl-oxolan-2-yl]methoxy-oxidanyl-phosphoryl] hydrogen phosphate

[(2~{R},3~{R},4~{S},5~{S},6~{R})-4-acetamido-6-methyl-3,5-bis(oxidanyl)oxan-2-yl] [[(2~{R},3~{S},5~{R})-5-[5-methyl-2,4-bis(oxidanylidene)pyrimidin-1-yl]-3-oxidanyl-oxolan-2-yl]methoxy-oxidanyl-phosphoryl] hydrogen phosphate

C18H29N3O15P2 (589.1073864000001)


   
   
   

dTDP-4-acetamido-4,6-dideoxy-alpha-D-galactose

dTDP-4-acetamido-4,6-dideoxy-alpha-D-galactose

C18H29N3O15P2 (589.1073864000001)


   
   

UDP-2-acetamido-2,6-dideoxy-beta-L-lyxo-hex-4-ulose

UDP-2-acetamido-2,6-dideoxy-beta-L-lyxo-hex-4-ulose

C17H25N3O16P2 (589.071003)


   

GDP-fucose

[({[3,4-dihydroxy-5-(6-hydroxy-2-imino-3,9-dihydro-2H-purin-9-yl)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy][(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]phosphinic acid

C16H25N5O15P2 (589.0822360000001)


GDP-L-fucose is a sugar nucleotide and a readily available source of fucose. Fucose is a deoxyhexose that is found in nearly all plant and animal species. The monosaccharide plays several important metabolic roles in complex carbohydrates and in glycoproteins. Fucosylated oligosaccharides are involved in cell-cell recognition, selectin-mediated leukocyte-endothelial adhesion, and mouse embryogenesis. They form the basis of the Lewis-type blood group antigens, are involved in the formation of atherosclerosis, and mediate host-bacterial interactions. A decrease in the availability of fucose is associated with leukocyte adhesion deficiency type-II disorder, and fucosylated glycoproteins have been implicated in memory processes. Fucose is made available during the synthesis of fucosylated glycolipids, oligosaccharides, and glycoproteins via a sugar nucleotide intermediate, specifically GDP-L-fucose. GTP-L-fucose pyrophosphorylase (GFPP, E. C. 2.7.7.30) catalyzes the reversible condensation of guanosine triphosphate and beta-L-fucose-1-phosphate to form the nucleotide-sugar GDP-L-fucose. The enzyme functions primarily in the mammalian liver and kidney to salvage free L-fucose during the breakdown of glycolipids and glycoproteins. (PMID: 16086588) [HMDB]

   

ADP-glucose

Adenosine diphosphate glucose

C16H25N5O15P2 (589.0822360000001)


   

((2R,3R,4S,5R)-5-(2-amino-6-oxo-1,6-dihydropurin-9-yl)-4-hydrogen sulfate-3-((2S,4S,5S)-3,4,5-trihydroxy-6-methyl-tetrahydro-2H-pyran-2-yloxy)-tetrahydrofuran-2-yl)methyl hydrogen sulfate

((2R,3R,4S,5R)-5-(2-amino-6-oxo-1,6-dihydropurin-9-yl)-4-hydrogen sulfate-3-((2S,4S,5S)-3,4,5-trihydroxy-6-methyl-tetrahydro-2H-pyran-2-yloxy)-tetrahydrofuran-2-yl)methyl hydrogen sulfate

C16H23N5O15S2 (589.0632048000001)


   

Adenosine-5-diphospho-glucose disodium salt

Adenosine-5-diphospho-glucose disodium salt

C16H25N5O15P2 (589.0822360000001)


   
   
   
   

TDP-4-acetamido-4,6-Dideoxy-D-galactose

TDP-4-acetamido-4,6-Dideoxy-D-galactose

C18H29N3O15P2 (589.1073864000001)


   

Pinaverium bromide

L-Pinaverium bromide

C26H41Br2NO4 (589.1402145999999)


C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker

   
   

[[5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hydrogen phosphate

[[5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hydrogen phosphate

C16H25N5O15P2 (589.0822360000001)


   
   
   

UDP-N-acetyl-beta-L-fucosamine(2-)

UDP-N-acetyl-beta-L-fucosamine(2-)

C17H25N3O16P2-2 (589.071003)


   

UDP-4-amino-4,6-dideoxy-N-acetyl-beta-L-altrosamine

UDP-4-amino-4,6-dideoxy-N-acetyl-beta-L-altrosamine

C17H27N4O15P2- (589.0948112000001)


   

UDP-N-acetyl-alpha-D-quinovosamine

UDP-N-acetyl-alpha-D-quinovosamine

C17H25N3O16P2-2 (589.071003)


   

UDP-2-acetamido-2,6-dideoxy-beta-L-talose(2-)

UDP-2-acetamido-2,6-dideoxy-beta-L-talose(2-)

C17H25N3O16P2-2 (589.071003)


   

UDP-N-acetyl-alpha-D-fucosamine

UDP-N-acetyl-alpha-D-fucosamine

C17H25N3O16P2-2 (589.071003)


   

UDP-4-amino-4,6-dideoxy-N-acetyl-beta-L-idosamine

UDP-4-amino-4,6-dideoxy-N-acetyl-beta-L-idosamine

C17H27N4O15P2- (589.0948112000001)


   

UDP-N-acetyl-beta-L-rhamnosamine

UDP-N-acetyl-beta-L-rhamnosamine

C17H25N3O16P2-2 (589.071003)


   

UDP-N-acetyl-beta-L-quinovosamine

UDP-N-acetyl-beta-L-quinovosamine

C17H25N3O16P2-2 (589.071003)


   

UDP-acetamido-4-amino-6-deoxygalactopyranose

UDP-acetamido-4-amino-6-deoxygalactopyranose

C17H27N4O15P2- (589.0948112000001)


   

dTDP-2,3,6-trideoxy-3-C-methyl-4-O-methyl-3-nitro-beta-L-arabino-hexopyranose

dTDP-2,3,6-trideoxy-3-C-methyl-4-O-methyl-3-nitro-beta-L-arabino-hexopyranose

C18H29N3O15P2 (589.1073864000001)


   

UDP-N-acetylgalactosamine-5,6-ene

UDP-N-acetylgalactosamine-5,6-ene

C17H25N3O16P2 (589.071003)


A UDP-amino sugar having N-acetylgalactosamine-5,6-ene as the amino sugar component.

   

UDP-4-acetamido-4,6-dideoxy-alpha-L-galactose

UDP-4-acetamido-4,6-dideoxy-alpha-L-galactose

C17H25N3O16P2-2 (589.071003)


   

[hydroxy-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphoryl] [(2R,4S,5R,6R)-5-methoxy-4,6-dimethyl-4-nitrooxan-2-yl] hydrogen phosphate

[hydroxy-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphoryl] [(2R,4S,5R,6R)-5-methoxy-4,6-dimethyl-4-nitrooxan-2-yl] hydrogen phosphate

C18H29N3O15P2 (589.1073864000001)


   

[(2R,3R,4R,5S)-3-acetamido-4,5-dihydroxy-6-methylideneoxan-2-yl] [[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] hydrogen phosphate

[(2R,3R,4R,5S)-3-acetamido-4,5-dihydroxy-6-methylideneoxan-2-yl] [[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] hydrogen phosphate

C17H25N3O16P2 (589.071003)


   

thymidine 5-[3-(4-acetamido-4,6-dideoxy-D-galactopyranosyl) dihydrogen diphosphate]

thymidine 5-[3-(4-acetamido-4,6-dideoxy-D-galactopyranosyl) dihydrogen diphosphate]

C18H29N3O15P2 (589.1073864000001)


   
   

UDP-2-acetamido-4-dehydro-2,6-dideoxy-beta-D-glucose

UDP-2-acetamido-4-dehydro-2,6-dideoxy-beta-D-glucose

C17H25N3O16P2 (589.071003)


   

UDP-2-acetamido-4-amino-2,4,6-trideoxy-D-glucose(1-)

UDP-2-acetamido-4-amino-2,4,6-trideoxy-D-glucose(1-)

C17H27N4O15P2- (589.0948112000001)


   
   

[[(2S,3R,4S,5S)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl] hydrogen phosphate

[[(2S,3R,4S,5S)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl] hydrogen phosphate

C16H25N5O15P2 (589.0822360000001)


   

GDP-L-fucose

GDP-L-fucose

C16H25N5O15P2 (589.0822360000001)


A GDP-fucose in which the fucosyl residue has L-configuration.

   
   

UDP-2-acetamido-2,6-dideoxy-alpha-D-xylo-hex-4-ulose

UDP-2-acetamido-2,6-dideoxy-alpha-D-xylo-hex-4-ulose

C17H25N3O16P2 (589.071003)


   
   

dTDP-4-acetamido-4,6-dideoxy-alpha-D-glucose

dTDP-4-acetamido-4,6-dideoxy-alpha-D-glucose

C18H29N3O15P2 (589.1073864000001)


   

dTDP-4-dimethylamino-4,6-dideoxy-5-C-methyl-L-mannose

dTDP-4-dimethylamino-4,6-dideoxy-5-C-methyl-L-mannose

C19H33N3O14P2 (589.1437698000001)


   

ADP alpha-D-glucoside

ADP alpha-D-glucoside

C16H25N5O15P2 (589.0822360000001)


An ADP-aldose having alpha-D-glucopyranose as the sugar moiety.

   

GDP-beta-L-Fucose

GDP-beta-L-Fucose

C16H25N5O15P2 (589.0822360000001)


A GDP-L-fucose in which the anomeric oxygen is on the same side of the fucose ring as the methyl substituent.

   
   
   

6H05 (TFA)

6H05 (TFA)

C22H31ClF3N3O4S3 (589.1117232)


6H05 TFA is a selective, and allosteric inhibitor of oncogenic mutant K-Ras(G12C). IC50 value: Target: K-Ras G12C 6H05 gives the greatest degree of modification, which allosterically modifies the oncogenic G12C mutant of highly homologous protein H-Ras without affecting wild-type K-Ras [1]. 6H05 can be used as an intermediate for the synthesis of other oncogenic K-Ras(G12C) inhibitors [2].

   

{[(2s,3s,4r,5s)-3,4-dihydroxy-5-(6-hydroxy-2-imino-3h-purin-9-yl)oxolan-2-yl]methoxy(hydroxy)phosphoryl}oxy([(2s,3s,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy)phosphinic acid

{[(2s,3s,4r,5s)-3,4-dihydroxy-5-(6-hydroxy-2-imino-3h-purin-9-yl)oxolan-2-yl]methoxy(hydroxy)phosphoryl}oxy([(2s,3s,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy)phosphinic acid

C16H25N5O15P2 (589.0822360000001)


   

{[(2r,3r,4s,5s)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy(hydroxy)phosphoryl}oxy([(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy)phosphinic acid

{[(2r,3r,4s,5s)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy(hydroxy)phosphoryl}oxy([(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy)phosphinic acid

C16H25N5O15P2 (589.0822360000001)


   

{[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy(hydroxy)phosphoryl}oxy([3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy)phosphinic acid

{[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy(hydroxy)phosphoryl}oxy([3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy)phosphinic acid

C16H25N5O15P2 (589.0822360000001)